جست‌وجوی استاد و پژوهشگر

David Antonettiمشاهده پروفایل

استاد

• Diabetic Retinopathy
• Stroke
• Blood-Retinal Barrier
• +۵ مورد دیگر

David Antonetti, Ph.D., serves as Professor and Scientific Director at the University of Michigan's Kellogg Eye Center within the Department of Ophthalmology and Visual Sciences. His laboratory actively accepts new students and maintains dual appointments in Molecular & Integrative Physiology. Antonetti directs research focused on vascular barrier mechanisms with significant implications for diabetic complications and stroke. His research centers on the tight junction complex in blood-retinal and blood-brain barriers, investigating how diabetes and stroke compromise vascular integrity. Antonetti's lab pioneered the discovery that occludin phosphorylation regulates barrier properties, demonstrating that transgenic mice expressing phosphorylation-resistant occludin mutants preserve retinal vascular function during diabetes. Current work explores Norrin cytokine therapy for barrier restoration and occludin phosphorylation targeting for stroke treatment using biochemical, cell biological, and transgenic approaches. Award highlights include the Jules Francois Prize (2004), Hinkle Society Translational Research Award (2007), and Roger W. Kittendorf Research Professorship (2019). His publication trends reveal sustained focus on vascular permeability mechanisms, with recent emphasis on Norrin signaling, disheveled-claudin interactions, and therapeutic repurposing for diabetic retinopathy and stroke. Jules Francois Prize for Young Investigator in Ophthalmology (2004) Hinkle Society Mid-Career Translational Research Award (2007) Most Inspirational Teacher Award (2009) Jules and Doris Stein Professorship (2011) Roger W. Kittendorf Research Professorship (2019) Antonetti leads collaborative research with Dr. Dan Lawrence on blood-brain barrier mechanisms in stroke, and directs multiple institutional resources including the Michigan Research Experts Profile. His laboratory develops transgenic models and molecular techniques to translate barrier biology discoveries into novel therapeutics, with recent work focusing on controlled antibody delivery systems and repurposed drugs for vascular protection. The Antonetti lab operates within the Kellogg Eye Center's research infrastructure, utilizing advanced techniques including mass spectrometry, mutational analysis in endothelial cell culture, transgenic mouse modeling, and optical coherence tomography. Current projects investigate neurovascular unit interactions, occludin-dynein mechanics, and Norrin-based therapeutics for diabetic retinopathy, with strong translational emphasis on vision preservation.

Michael Francis Wanglerمشاهده پروفایل

دانشیار

• Pediatric genetics
• Peroxisomal disorders
• Medical genetics
• +۴ مورد دیگر

Dr. Michael Francis Wangler is an Associate Professor at Baylor College of Medicine within the Graduate School of Biomedical Sciences and Department of Molecular & Human Genetics . His research focuses on pediatric genetics and peroxisomal disorders , using Drosophila models and genomics to study Mendelian disease mechanisms. Co-Director of Model Organisms Screening Center (MOSC) for Undiagnosed Diseases Network Active in clinical genetics at Texas Children's Hospital Research interests include: Deciphering molecular pathogenesis of rare diseases Genomics and metabolomics in peroxisome biogenesis disorders Functional validation of de novo variants Model organism applications in clinical genetics Recent publications highlight work on: DDX39B , RBBP5 , and DNMT3A variant-associated syndromes Biomarker discovery in peroxisomal diseases Neurodevelopmental disorder mechanisms via Drosophila Laboratory: Duncan Neurological Research Institute (Room DNRI-1050, Houston, TX)

Caroline Quachمشاهده پروفایل

استاد

• Infection Prevention
• Bacteriology
• Virology
• +۴ مورد دیگر

Dr. Caroline Quach is a full professor at the University of Montreal, holding appointments in the Departments of Microbiology and Immunology, and Pediatrics. She serves as an associate professor at McGill University's Department of Epidemiology, Biostatistics and Occupational Health, and as a scientific collaborator at Université libre de Bruxelles' School of Public Health. As Infection Prevention & Control Officer at CHU Sainte-Justine, she combines clinical practice (microbiologist-infectious disease specialist) with research leadership through her Canada Research Chair Tier 1 in Infection Prevention. Full Professor - University of Montreal Associate Professor - McGill University Scientific Collaborator - Université libre de Bruxelles Infection Prevention & Control Officer - CHU Sainte-Justine Her research focuses on infection prevention , particularly nosocomial infections and vaccine-preventable diseases . Key areas include: Central catheter bacteremia prevention Respiratory infection control in hospitals Vaccination program effectiveness Managing infections in vulnerable populations Recent publications demonstrate expertise in microbial diagnostics , outbreak investigation , and clinical epidemiology across pediatric and public health settings. Scientific recognition includes: Fellow, Canadian Academy of Health Sciences Fellow, Society for Healthcare Epidemiology of America Canada's Most Powerful Women 2019 - Science & Technology category Dr. Quach advises research teams at CHU Sainte-Justine, collaborating with lab staff including Zineb Laghdir, Deirdre McCormack, and Kelsey Adams. She previously chaired Canada's National Advisory Committee on Immunization (2017-2021) and led AMMI Canada (2014-2016).

• Neuroscience
• Neurophysiology
• Synaptic Function
• +۳ مورد دیگر

Dr. Wei Ba is a Researcher in the Department of Life Sciences at Imperial College London, affiliated with the Faculty of Natural Sciences. Based at the Sir Ernst Chain Building on the South Kensington Campus, their work focuses on neurophysiological mechanisms, synaptic function, and neurodevelopmental disorders. Dr. Ba's research explores the interplay between neural circuits and behaviors, particularly in contexts such as sleep regulation, anxiety, and intellectual disability. Research interests include the role of GABAergic and glutamatergic systems in sleep-wake cycles, basal ganglia circuits in anxiety regulation, and the genetic and molecular basis of neurodevelopmental disorders. Their studies often employ animal models to investigate synaptic plasticity, epigenetic regulation (e.g., histone methylation), and the impact of genetic mutations on neuronal function. Notable contributions include identifying neuronal hubs linking sleep initiation with thermoregulation, elucidating how GABA B receptor signaling contributes to schizophrenia-like phenotypes in rats, and discovering mechanisms underlying intellectual disability via proteins like SVBP and TRIO. Dr. Ba's work bridges molecular neuroscience with behavioral outcomes, addressing fundamental questions in neural circuitry and disease pathophysiology.

Hsiao-Tuan Chaoمشاهده پروفایل

استادیار

• Neurodevelopmental disorders
• Autism spectrum disorders
• Epilepsy genetics
• +۷ مورد دیگر

Dr. Hsiao-Tuan Chao is an Assistant Professor at Baylor College of Medicine with primary appointments in the Department of Pediatrics (Division of Neurology and Developmental Neuroscience), Department of Molecular and Human Genetics, and Department of Neuroscience. She serves as an Investigator at the Jan and Dan Duncan Neurological Research Institute and Texas Children's Hospital, and is a McNair Scholar at the McNair Medical Institute. Dr. Chao also holds leadership roles as Associate Program Director for the Basic Neuroscience Pathway in the Child Neurology Residency Training Program and as a Faculty Senator at Baylor College of Medicine. Dr. Chao's educational background includes: MD from Baylor College of Medicine (2012) PhD in Neuroscience from Baylor College of Medicine (2010) BS in Neuroscience and BA in Biochemistry (summa cum laude) from University of Texas at Austin (2002) Plan II Honors in Liberal Arts (summa cum laude) from University of Texas at Austin (2002) Her research focuses on understanding the genetic and neurophysiologic underpinnings of neurodevelopmental disorders including intellectual disability, epilepsy, autism, and schizophrenia. A central theme in her work is examining how disrupted inhibitory neuronal development and function contribute to these conditions. The Chao Lab integrates cross-species approaches using human genomics to uncover genetic etiologies, fruit flies to elucidate molecular pathways, and mice to explore consequences in the mammalian brain. Key research areas include EBF3-related disorders (HADDS syndrome), STXBP1 encephalopathy, EIF2AK variants (LEUDEN and LEMPSAD syndromes), and PPFIA3-related neurodevelopmental disorders. Analysis of Dr. Chao's recent publications reveals a strong focus on identifying novel disease genes and characterizing genotype-phenotype relationships in neurodevelopmental disorders. Her work spans multiple technical approaches including whole-genome sequencing, RNA sequencing, DNA methylation analysis, and functional validation using model organisms. A significant portion of her research examines how specific genetic variants impact protein function and neuronal development, with particular attention to transcriptional regulation, protein translation, and synaptic function. Dr. Chao has received numerous prestigious awards recognizing her contributions to neuroscience and neurology: 2022 "40 Under 40" List of Autism Researchers (Global Rising Stars in Autism Research) 2022 Young Investigator Award from Baylor College of Medicine Department of Pediatrics 2022 Induction to the Society for Pediatric Research 2020 Philip R. Dodge Young Investigator Award from the Child Neurology Society 2019 Health Care Heroes - Rising Star Award from Houston Business Journal 2017 STAT Wunderkind Award Dr. Chao actively mentors a large team of researchers including postdoctoral fellows, graduate students, medical students, and genetic counseling students. Her lab has secured significant funding including an NIH R01 grant (Molecular and Cellular Mechanisms of Cerebellar Dysfunction in Neurodevelopmental disorders), a DP5 Early Independence Award from NIH, and funding from the Burroughs Wellcome Fund. Current research initiatives include the Undiagnosed Epilepsy Genetics Initiative, EBF3-related disorders research study, and a Phase 1/2a clinical trial of CAP-002 Gene Therapy for STXBP1 Encephalopathy. The Chao Lab operates within the Jan and Dan Duncan Neurological Research Institute, leveraging multiple core facilities including the Microscopy Core, Rodent Neurobehavior Core, High Throughput Behavioral Screening Core, and Optogenetics and Viral Vectors Core. Her team collaborates extensively with the Undiagnosed Diseases Network and maintains active partnerships with clinicians at Texas Children's Hospital to translate research findings into clinical applications.

• Neurodegenerative Diseases
• Motor Neuron Biology
• Genetic Disorders
• +۵ مورد دیگر

Dr. James Orengo, Associate Professor at Baylor College of Medicine and Director of the Multi-disciplinary ALS Clinic at Michael E. DeBakey VA Medical Center, focuses his research on motor neuron degeneration in neurodegenerative diseases like Spinocerebellar Ataxia Type 1 (SCA1) and ALS . His lab employs mouse models , transgenic zebrafish lines , and human iNeurons to investigate disease mechanisms. Key research areas include: Pathogenic drivers of bulbar dysfunction in SCA1 Transcriptomics of motor neuron degeneration Cross-species modeling (Human, Mouse, Zebrafish) Collaborations with the Undiagnosed Diseases Network (UDN) Dr. Orengo also contributes to clinical care through the BCM ALS Clinic and co-leads multidisciplinary teams at the Michael E. DeBakey VA Medical Center . His lab develops tools for CRISPRi screens and live imaging in zebrafish to accelerate therapeutic discovery.

Michael Sacherمشاهده پروفایل

استاد

• Membrane Traffic
• Vesicle Recognition
• TRAPP-opathies
• +۵ مورد دیگر

Michael Sacher is a Professor in the Department of Biology at Concordia University. His research focuses on membrane traffic, vesicle recognition, and TRAPP complex-related disorders, particularly TRAPP-opathies and TANGO2 deficiency diseases. He holds a PhD from McGill University and has been awarded grants from CIHR, NSERC, and the TANGO2 Research Foundation. His work combines cell biology, genetics, and clinical research to understand disease mechanisms and develop therapeutic strategies. Key contributions include studies on autophagy regulation, protein glycosylation defects, and the molecular basis of muscular dystrophies. Teaching activities include Cell Biology (Biol 266) and Advanced Laboratory in Molecular Biology (Biol 466/689). His lab investigates the TRAPP complex’s role in organelle communication, with recent studies highlighting lipid imbalances in TANGO2 deficiency and vitamin B5’s therapeutic potential. Awards include the CIHR New Investigator Award (2007-2012) and the Maud Menten Prize (2007). His research bridges basic science and clinical applications, with ongoing work on patient-derived cell models and zebrafish/humanized yeast systems. Lab Website: Visit our lab pages Grants: CIHR, NSERC, Concordia University, TANGO2 Foundation Recent Focus: TRAPP mutations in neurodevelopmental disorders, autophagy regulation, and ER-Golgi trafficking defects

Matt Guilleمشاهده پروفایل

استاد

• Developmental Genetics
• Gene Regulation
• Epigenetics
• +۵ مورد دیگر

Professor Matt Guille is a leading researcher in developmental genetics at the University of Portsmouth's School of the Environment and Life Sciences. His work focuses on gene regulation in Xenopus embryos, spanning transcription factors, epigenetic mechanisms, and chromatin dynamics. He also contributes to marine biology through molecular genetics collaborations and leads the European Xenopus Resource Centre, which provides critical infrastructure for developmental biology research. PhD in Biochemistry from King’s College London Postdoctoral fellowships at Cancer Research UK and Developmental Biology Research Centre Established independent lab at Portsmouth in 1990s Founded European Xenopus Resource Centre (2006, Wellcome Trust funded) Research interests center on early embryonic development in Xenopus, including: Transcription factor activity control Variant histone function Chromatin regulation Xenopus welfare and methodology improvements Marine genetics applications His recent publications highlight Xenopus as a platform for modeling human genetic disorders like neurodevelopmental syndromes and intellectual disabilities. He has developed innovative techniques including CRISPR-Cas9 miRNA knockout methods and quantitative redox assays. Scientific contributions include: Wellcome Trust funding for European Xenopus Resource Centre Leadership in Xenopus model development Advancements in protein thiol redox measurement As a PhD supervisor, he guides students in developmental genetics while maintaining active laboratory research. He previously served as head of school but has now returned to hands-on research in Portsmouth’s thriving epigenetics and developmental biology environment.

Dara Brodskyمشاهده پروفایل

استادیار

• Neonatology
• Medical Education
• Neonatal Intensive Care
• +۷ مورد دیگر

Dara Brodsky, MD, is an Assistant Professor in Pediatrics at Harvard Medical School and a neonatologist at Beth Israel Deaconess Medical Center (BIDMC), where she also serves as Associate Director of the Neonatal Intensive Care Unit. She is actively involved in the Harvard Neonatology Fellowship Program and holds leadership roles in medical education. Associate Director, NICU, Beth Israel Deaconess Medical Center Assistant Professor, Department of Pediatrics, Harvard Medical School Co-Director, Newborn Medicine Summer Student Research Program Chair, Neonatology Curriculum Committee, Harvard Neonatology Fellowship Member, Academy at Harvard Medical School Her research and academic work focus on medical education , neonatal care , and educational evaluation tools . She has contributed significantly to curriculum development, faculty assessment, and the creation of foundational educational resources such as the Neonatology Review series and Primary Care of the Premature Infant . Her interests extend to clinical ethics, genomics, and the integration of artificial intelligence in neonatal medicine. Dr. Brodsky's recent publications reflect a growing emphasis on AI in medical education , particularly the performance of large language models on neonatal board exams. Other key themes include fetal physiology , end-of-life care in the NICU , team collaboration , and innovative teaching methodologies . Her work bridges clinical practice with educational innovation. Scientific Awards: Senior Resident Teacher of the Year Award, Columbia-Presbyterian Medical Center 2010 Merton Bernfield Teaching Award in Neonatology Dr. Brodsky has advised numerous trainees through her educational programs and has led curriculum development initiatives supported by institutional and academic grants. She co-directs a summer research program for students in newborn medicine and has developed web-based educational tools for resident training. Her leadership in the Academy at Harvard Medical School underscores her commitment to educational excellence. She is actively involved in the editorial work for NeoReviews , an American Academy of Pediatrics-sponsored journal, and contributes to shaping the future of neonatology education through curriculum design and policy. Her work fosters interdisciplinary, family-centered care models in the NICU.

• Neurogenetics
• Developmental Biology
• Cell Biology
• +۴ مورد دیگر

Boris August Egger is a Senior Researcher and Lecturer in Light Microscopy and Neurogenetics at the Department of Biology, University of Fribourg, Faculty of Science and Medicine. His work focuses on Drosophila neurogenetics, neural stem cell dynamics, and advanced microscopy techniques. Senior Researcher, Department of Biology, University of Fribourg Lecturer in Light Microscopy and Neurogenetics Head of Bioimage Core Facility His research explores neural stem cell division , hypoxia responses in the developing brain , and genetic regulation of brain structure using Drosophila as a model organism. Key methodologies include live cell imaging , super-resolution microscopy , and genetically encoded biosensors . Recent publications highlight work on centrosome asymmetry , Notch signaling in stem cell regulation , and hypoxia response mechanisms . He also contributes to technical advancements in fluorescence microscopy and in vivo imaging .

Julia Paganمشاهده پروفایل

دانشیار

• Ubiquitin Proteasome System
• Mitochondrial Biology
• Centrosome Regulation
• +۴ مورد دیگر

Associate Professor Julia Pagan leads the Targeted Protein Degradation lab at the School of Biomedical Sciences, The University of Queensland. With a PhD from UQ, her research focuses on the ubiquitin proteasome system (UPS) in regulating cellular homeostasis through centrosome, microtubule, and mitochondrial quality control. Her work has implications for cancers, neurodegenerative disorders, and mitochondrial diseases. Bachelor of Science (UQ) Bachelor (Honours) of Science (Advanced) (UQ) Doctor of Philosophy (UQ) Research Interests : Investigates UPS mechanisms in organelle regulation, particularly: Mitochondrial biology and mitophagy receptors (BNIP3/NIX) Centrosome-microtubule dynamics in cell division Ubiquitin ligase pathways in disease contexts Therapeutic targeting of protein degradation Publication Trends : Recent articles (2023-2025) emphasize mitophagy regulation, mitochondrial diseases, and AI-driven cancer stress assays. Earlier work (2009-2018) explores centrosome biology, DNA repair, and UPS roles in heart disease and neurodevelopment. Scientific Awards : ARC Future Fellowships (2019-2023) Supervision & Grants : Mentors PhD students in mitochondrial diseases and organelle regulation. Current grants include NHMRC IDEAS Grants (2023-2025) and Australian Functional Genomics Network funding (2025-2026). Former grants targeted Parkinson's disease, cardiac stress responses, and DNA replication defects.

Yanjin Zhangمشاهده پروفایل

دانشیار

• Molecular Virology
• Virus-Cell Interactions
• Innate Immunity
• +۳ مورد دیگر

Dr. Yanjin Zhang serves as an Associate Professor in the School of Veterinary Medicine at the University of Maryland, College Park. His research focuses on molecular virology of RNA viruses including PRRSV, HEV, and Zika virus, with particular expertise in virus-host interactions and innate immune evasion mechanisms. Research Interests: Dr. Zhang investigates viral pathogenesis and mechanisms of viral interference with host innate immunity, especially interferon induction and JAK-STAT signaling pathways. His laboratory discovered that PRRSV inhibits STAT1/2/3 signaling and that HEV ORF1 blocks interferon induction while ORF3 activates RIG-I signaling. Current projects center on vaccine development against PRRSV using a novel interferon-inducing strain that enhances neutralizing antibody responses. Publication Trends: Analysis of 12 recent publications (2009-2023) reveals consistent focus on viral antagonism of host defense systems. Key themes include viral protein-induced degradation of host factors (e.g., KPNA2 by Zika NS2A), disruption of interferon signaling cascades, and karyopherin-mediated nuclear transport mechanisms. Primary subfields span neurovirology (Zika), porcine virology (PRRSV), and zoonotic hepatitis (HEV). Laboratory: Dr. Zhang directs a research team investigating molecular mechanisms of virus-host interactions with direct applications in antiviral therapeutic and vaccine development against economically significant viral pathogens.

• DNA damage response
• Genome maintenance
• Cancer biology
• +۵ مورد دیگر

Thorkell Gudjónsson is an Assistant Professor at the Biotech Research & Innovation Centre (BRIC) at the University of Copenhagen, where he leads research within the Sørensen Group. His work primarily focuses on genome stability mechanisms and their implications in cancer development. Dr. Gudjónsson's research interests center on DNA damage response pathways, chromatin biology, and molecular mechanisms underlying cancer development. His work bridges basic molecular biology with translational cancer research, particularly in breast cancer and other malignancies. He investigates how genome maintenance pathways function under normal conditions and how their dysregulation contributes to carcinogenesis. Analysis of his publication record reveals a consistent focus on DNA repair mechanisms and their relationship to cancer. His most recent work (2024-2025) has centered on tumor suppressors in breast cancer, replication stress disorders, and cytoskeletal proteins that maintain genome integrity. Earlier work established foundational knowledge about chromatin modifications during DNA damage response, with highly cited papers in Cell and Molecular Cell. His research has generated significant scientific impact, with several papers accumulating hundreds of citations, particularly his 2012 Cell paper on TRIP12 and UBR5 which has received over 300 citations. His work appears in high-impact journals including Cell, Nature Communications, and The Journal of Clinical Investigation. As a principal investigator within the Sørensen Group at BRIC, Dr. Gudjónsson collaborates extensively with researchers across multiple institutions, with particular strength in interdisciplinary cancer research combining molecular biology, genetics, and clinical medicine. His laboratory employs advanced techniques in molecular and cellular biology to investigate fundamental mechanisms of genome maintenance.

Chil-Yong Kangمشاهده پروفایل

استاد

• Vaccinology
• Molecular Virology
• Antiviral Therapeutics
• +۳ مورد دیگر

Chil-Yong Kang is a Professor of Virology in the Department of Microbiology and Immunology at the Schulich School of Medicine and Dentistry, University of Western Ontario, Canada. He is a molecular virologist with a distinguished career spanning academia and leadership roles, including Chairmanship of Microbiology and Immunology at the University of Ottawa and Dean of Science at Western Ontario (1992–1999). PhD in Virology from McMaster University (1971). Postdoctoral training at the University of Wisconsin-Madison (1971–1974) under Nobel Laureate Howard Temin. Doctor of Science (D.Sc.) from McMaster University and Carleton University. Dr. Kang’s research focuses on developing antiviral vaccines and therapeutic agents for diseases such as hepatitis C, Ebola, MERS, Zika virus microcephaly, and HIV/AIDS. Notable achievements include the SAV001 HIV vaccine (completed Phase I trials) and a replication-competent SARS-CoV-2 vaccine platform. He has authored 148 peer-reviewed papers and holds 15 international biotechnology patents covering over 70 countries. Scientific awards and honors include: Korean-Canadian Heritage Award (1989) Ho-Am Prize in Medicine (1999) Order of Innovation from the Republic of Korea (2002) Queen Elizabeth II Diamond Jubilee Medal (2012) Life-time Fellow of the Royal Society of Canada (1993) He has served on grant selection committees for Canadian and U.S. federal agencies, participated in the Science Technology Innovation Council (STIC) of Canada, and reviewed for journals including Journal of Virology and Journal of Biological Chemistry . Dr. Kang leads the Kang Lab, contributing to vaccine innovation and molecular virology research.

Catherine Y. Spongمشاهده پروفایل

استاد

• Maternal and child health
• Prematurity
• Fetal complications
• +۷ مورد دیگر

Catherine Y. Spong, M.D. serves as Professor and Chair of the Department of Obstetrics and Gynecology at UT Southwestern Medical Center, where she also holds clinical responsibilities at the Parkland Health and Hospital System. Prior to her current position, she served as Vice Chair for the Department and Chief of the Division of Maternal-Fetal Medicine at UT Southwestern, having joined the faculty in 2018 after a distinguished 23-year career at the National Institutes of Health (NIH). Dr. Spong earned her medical degree from the University of Missouri-Kansas City (UMKC) in 1991, followed by serving as Chief Resident in Obstetrics and Gynecology at the Harbor-UCLA Medical Center. Her extensive NIH career included leadership positions at the National Institute of Child Health and Human Development (NICHD), where she served as Deputy Director, Acting Director, Associate Director for Extramural Research, Director of the Division of Extramural Research, and Chief of the Pregnancy and Perinatology Branch. She chaired the Department of Health and Human Services (DHHS) Federal Task Force on Research Specific to Pregnant Women and Lactating Women. Dr. Spong's research focuses on maternal and child health with emphasis on prematurity, fetal complications, and improving child outcomes. She directs significant research on the developing fetus, neuroprotective peptides, and fetal development. Her work spans fetal alcohol syndrome, Down syndrome, stillbirth, fetal surgery for myelomeningocele, Zika virus in pregnancy, and the human placenta. She launched the Human Placenta Project during her NIH tenure and is a passionate advocate for inclusion of underrepresented groups in research, stating 'We must recognize that inclusion is better than absence of data on treatment.' Analysis of Dr. Spong's recent publications reveals a strong focus on critical issues in maternal-fetal medicine, particularly Zika virus and pregnancy, placental research, and health disparities. Her work spans multiple disciplines including obstetrics, infectious disease, public health, and medical ethics, with consistent emphasis on improving outcomes for mothers and children through evidence-based research. Society for Maternal-Fetal Medicine Achievement Award UMKC Alumnus of the Year Award Multiple NIH Director's Awards Surgeon General's Certificate of Appreciation for work on prematurity Dr. Spong has made significant editorial contributions as Editor of 'William's Obstetrics,' 'Management of High Risk Pregnancy,' 'Protocols for High-Risk Pregnancies,' and 'Stillbirth: Prediction, Prevention and Management.' With over 270 peer-reviewed publications, she has appeared on national media including The CBS Early Show, Diane Rehm Show, NPR's All Things Considered, CNN, and Voice of America to discuss women's health topics. Her research on fetal neuroprotection has led to several patents for neuroprotective agents that help prevent fetal injury. As Chair at UT Southwestern, Dr. Spong oversees one of the premier academic departments of Obstetrics and Gynecology in the United States, with ongoing leadership in major research initiatives including the Human Placenta Project and continued advocacy for inclusive research practices that improve maternal and fetal outcomes.